Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion type Assertion NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_head.
- NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion wasGeneratedBy ECO_0000203 NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_provenance.
- NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion wasDerivedFrom befree-2016 NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_provenance.
- NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion SIO_000772 24449822 NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_provenance.
- NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion evidence source_evidence_literature NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_provenance.
- NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_assertion description "[Mechanisms mediating androgen receptor (AR) reactivation in prostate cancer that progresses after castration (castration-resistant prostate cancer; CRPC) and subsequent treatment with abiraterone (CYP17A1 inhibitor that further suppresses androgen synthesis) remain unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147373.RAuYIil5S53nDiZEdToq7i_-0Hn1moZ-0yy_NUryP72J4130_provenance.